IVA · Inventiva S.A.
$4.64
+0.04 (+0.87%)
At close · Jul 28
Market Cap
$1.10B
Shares
236.22M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.64
Open$4.58
Day$4.52–4.66
52W$2.94–7.98
Avg vol 30d1.3M
Short int1.8M · 0.8% float · 1.0d
Short vol20%
Last earningsDec 31, 2025
DataJul 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−8%
below
Price vs 50-day avg
+8%
above
RSI (14)
60
neutral
MACD trend
Positive
52-week position
34%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+33%
trailing
6-month return
−25%
trailing
YTD return
0%
this year
Relative strength
−32%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
9 of 66 funds reported for Jun 30 · net +2.9M sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.76% of float · ▲ +25.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
66 holders — near 3-yr high, broad support
Squeeze score
56
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
85%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
5.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−8%
Bearish
Price vs 50-day avg
+8%
Bullish
RSI (14)
60
Neutral
MACD trend
Positive
Bullish
52-week position
34%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
9 of 66 funds reported for Jun 30 · net +2.9M sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.76% of float · ▲ +25.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
66 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $3
Now $5 · 34%
52-wk high $8
vs 200-day avg -8%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IVA
this stock
Inventiva S.A.
|
$1.10B | -0.2% | — | — | 0.8% |
|
ONC
BeOne Medicines Ltd.
|
$477.60B | +7.3% | +22179.2% | 971.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +8.2% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +3.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IVA | +3.6% | +32.6% | -25.0% | +22.8% | -0.2% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +4.6% | +32.6% | -32.5% | +23.5% | -8.9% |